SCHEMBL6214929

SCHEMBL6214929

NC(=O)c1sc(-n2cnc3cc(N)ccc32)cc1OCCc1ccccc1Cl

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 19/20 0.68
PLK3 Q9H4B4 3/20 0.63
MAP4K4 O95819 1/20 0.54
CSF1R P07333 1/20 0.54
PIM1 P11309 1/20 0.54
KDR P35968 1/20 0.54
NEK2 P51955 1/20 0.54
LIMK1 P53667 1/20 0.54
STK3 Q13188 1/20 0.54
CAMK2B Q13554 1/20 0.54
CAMK2G Q13555 1/20 0.54
CAMK2D Q13557 1/20 0.54
DYRK1A Q13627 1/20 0.54
CAMK1 Q14012 1/20 0.54
PKN2 Q16513 1/20 0.54
HIPK4 Q8NE63 1/20 0.54
BRSK1 Q8TDC3 1/20 0.54
AURKB Q96GD4 1/20 0.54
SLK Q9H2G2 1/20 0.54
CLK4 Q9HAZ1 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6214432 0.87 PLK1 (0.84) PLK1PLK3MAP4K4CSF1RKDR
SCHEMBL4402863 0.86 PLK1 (0.61) PLK1PLK3MAP4K4CSF1RPIM1
SCHEMBL6210332 0.83 PLK1 (0.56) PLK1PLK3NEK2
SCHEMBL5067368 0.80 PLK1 (0.78) PLK1PLK3PIM1KDRNEK2
SCHEMBL5008546 0.77 PLK1 (0.63) PLK1PLK3CYP2C9
SCHEMBL4404992 0.77 PLK1 (0.78) PLK1PLK3CSF1RCYP2C9
SCHEMBL5058244 0.76 PLK1 (1.00) PLK1PLK3MAP4K4CSF1RPIM1
SCHEMBL4406267 0.76 PLK1 (0.55) PLK1PLK3PIM1KDRNEK2
Trifluoroacetic Acid SCHEMBL4408558 0.76 PLK1 (0.54) PLK1PLK3MAP4K4CSF1RPIM1
SCHEMBL3732113 0.75 PLK1 (0.58) PLK1PLK3MAP4K4CSF1RKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546137-A1 BENZIMIDAZOL-1-YL-THIOPHENE COMPOUNDS FOR THE TREATMENT OF CANCER SmithKline Beecham Corporation (US) 2005-06-29 EP disclosed
WO-2004014899-A1 THIOPHENE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2004-02-19 WO disclosed